The Endocrine Disruptor Page HomeSitemap
 

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
 

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


 
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
1.4.2.2_10

 

contents  Detailed contents  << prev  next >>

  In a prospective cohort study on 171 healthy mother-child pairs in Düsseldorf, the cognitive and nerve development of children were evaluated by the BISD and Fagan tests at 7 months of age (Walkowiak et al., 1998). Follow-up was made by tests with BSID-II and Kaufman scale at 7, 18, 30 and 42 months of age. In addition, the home environment was evaluated using the HOME (Home Observation for Measurement of Environment) scale when the children were 18 months of age (Walkowiak et al., 2002). These data were used in an overall study of effects of PCB exposure on the intellectual and motor development of infants. Pre- and perinatal PCB exposure was evaluated by determining PCB-138, 153 and 180 in the cord blood of newborns and in breast milk. Significant inverse correlation was observed between milk PCB and baby's intellectual and motion development at the 30th and 42th month. Data for the 42th month indicate positive effects of good home environment on the child's development after the 30th month, while effects of PCB exposure via breast milk were also seen. It was thus suggested that prenatal PCB exposure at a background level retards mental and motor development of babies until the 42th month, but this effect is countered by favorable home environment which promotes the development.
Daniels et al. evaluated nerve development of 8 months-old babies by BSID test in a multicenter study on 1207 mother-child pairs from 12 regions in the U.S. conducted in 1959-65. As the measure for exposure, mothers' blood samples collected at every 8th week during gestation and the 6th week after delivery were analyzed for the total PCB including 11 homologues (PCB28, 52, 74, 105, 118, 138, 153, 170, 180, 194, 203). No correlation was found between mothers' serum PCB and children's mental and motion development (MDI and PDI scores) (Daniels et al., 2003). The lack of correlation between PCB exposure and MDI score as observed in this study was in agreement with findings of many precedent studies.
The 12 research institutes were not unanimous on the association of PCB exposure with motion development (PDI scores) in spite of standardization of timing of examination and procedure of PCB determination, presumably because of influences of uncontrolled factors such as food or exposure to mercury and lead.
Riva et al. (2004) studied association of colostrum PCB level and visual function at the 12th month of 25 infants born in Milan and its suburbs and breast-fed at least up to the 4th month. PCB 105, 118, 138, 153, 156 and 180, as well as DDT and DDE, in the colostrum collected two days after delivery and breast milk collected one and three months after delivery were analyzed. Long-chain polyunsaturated fatty acids (LC-PUFAs) C18:2 n-6, C18:3 n-3, C20:4 n-6. C20:5 n-3 and C22:6 n-3 in the plasma of all the infants were determined within the first 3 days after the birth. The colostral PCB as well as LC-PUFAs in plasma were considered to mirror perinatal supply. Visual function was evaluated by P100 latency of visually evoked potential (VEP) test at 12 months of age. Analysis found that P100 latency was correlated with DDT level (r = 0.513) and PCB level (r = 0.504) at a visual angle of 60 min, and with colostral levels of DDT, DDE and all the PCBs except PCB 105 (r = 0.401-0.618) at 15 min. Infant plasma levels of C22:6 n-3 were inversely associated with P100 wave latency at 60 min (r = -0.418) and at 1 Hz-2 J (r = -0.466). After controlling for C22:6 n-3, the partial correlation coefficient of P100 wave latency at 15 min to the colostral level of PCB 180 was 0.403 (p = 0.07). A weak relation was thus found between impaired visual function at 12 months of age of healthy infants and the levels of PCBs, DDT and DDE in colostrum. The effect of impairment was no longer evident after controlling for the plasma level of LC-PUFAs as found in the infant a few days after birth.
 

contents  Detailed contents  << prev  next >>

 

 

About links, copyright, etc. Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.